SEARCH FOR DNA MARKERS LINKED TO MANIC DEPRESSIVE ILLNESS IN THE OLD ORDER AMISH
在旧秩序阿米什人中寻找与躁狂抑郁症相关的 DNA 标记
基本信息
- 批准号:6111168
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
We are carrying out a genome-wide search to
identify chromosome regions that contain genes involved in bipolar
affective disorder (BPAD, manic depressive illness). Approximately
one percent of the population is afflicted by this severe cyclical
mood disorder and untreated patients with BPAD have an
approximately 20% risk of death from suicide. We are studying
several large families from the Old Order Amish population where
there is an even higher incidence of BPAD over several generations.
In these Old Order Amish families there may be a more limited
number of different genes contributing to the affective disorder
phenotype. In addition to the other reported linkages for BPAD,
(i.e. to chromosomes 4p, 4q, 11,12,18q, 21,22 and X), our results
suggest that genes on chromosome 6p SIBPAL (p<0.0001),
chromosome 13 SIBPAL (p=0.0003), and chromosome 15
SIBPAL (p=0.0003), have roles in increasing the susceptibility to
bipolar affective disorder. Also, rather than limiting our
genome-wide search to identifying susceptibility loci for BPAD, we
tested the hypothesis that "protective" alleles may contribute to the
absence of psychiatric illness (i.e., mental health "wellness") in
unaffected family members in these "high risk" families. We found
strong evidence for loci on chromosome 4p SIBPAL (p<0.00001;
GENEHUNTER NPL=3.8) and 4q SIBPAL (p<0.001;
GENEHUNTER NPL=4.7) that are linked to mental health
wellness suggesting that certain alleles could prevent or modify the
clinical manifestations of BPAD. The identification and
characterization of susceptibility and "protective" alleles should lead
to the development of more rational and direct approaches to
effective therapy for affective disorders.
我们正在进行全基因组搜索,
识别包含双极相关基因的染色体区域
情感障碍(BPAD,躁狂抑郁症)。约
百分之一的人口受到这种严重的周期性疾病的折磨,
情绪障碍和未经治疗的BPAD患者
自杀死亡的风险约为20%。我们正在研究
几个来自旧秩序阿米什人的大家庭,
在几代人中,BPAD的发病率甚至更高。
在这些旧秩序阿米什家庭可能有一个更有限的
导致情感障碍的不同基因的数量
表型除了所报告的与《巴塞尔公约》和《巴塞尔公约》评估和评价局的其他联系外,
(i.e.染色体4p,4 q,11,12,18 q,21,22和X),我们的结果
提示染色体6p上的基因SIBPAL(p<0.0001),
13号染色体SIBPAL(p=0.0003)和15号染色体
SIBPAL(p=0.0003)在增加对以下疾病的易感性方面发挥作用:
双相情感障碍此外,与其限制我们
全基因组搜索以确定BPAD的易感基因座,我们
测试了“保护性”等位基因可能有助于
没有精神疾病(即,心理健康(wellness)
这些“高风险”家庭中未受影响的家庭成员。我们发现
强有力的证据表明染色体4p上的基因座SIBPAL(p<0.00001;
GENEHUNTER NPL=3.8)和4q SIBPAL(p<0.001;
GENEHUNTER NPL=4.7)与心理健康有关
健康表明某些等位基因可以阻止或改变
BPAD的临床表现。确定和
易感性和“保护性”等位基因的特征应导致
制定更合理和直接的方法,
情感障碍的有效疗法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD I GINNS其他文献
EDWARD I GINNS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD I GINNS', 18)}}的其他基金
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
- 批准号:
7340503 - 财政年份:2006
- 资助金额:
-- - 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
- 批准号:
7547743 - 财政年份:2006
- 资助金额:
-- - 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
- 批准号:
7752542 - 财政年份:2006
- 资助金额:
-- - 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
- 批准号:
7164431 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Novel Orally Administered Macrophage Delivered Gene Ther
新型口服巨噬细胞传递基因疗法
- 批准号:
7022537 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Glucocerebrosidase Gene Transfer to the Nervous System
葡萄糖脑苷脂酶基因转移至神经系统
- 批准号:
6642183 - 财政年份:2002
- 资助金额:
-- - 项目类别:
CORRECTION OF INHERITED PROTEIN DEFICIENCEIS BY GENE THERAPY
通过基因疗法纠正遗传性蛋白质缺陷
- 批准号:
6111134 - 财政年份:
- 资助金额:
-- - 项目类别:
MOLECULAR GENETICS OF INHERITED NEUROLOGIC AND PSYCHIATRIC DISORDERS
遗传性神经和精神疾病的分子遗传学
- 批准号:
6111135 - 财政年份:
- 资助金额:
-- - 项目类别:
CORRECTION OF INHERITED PROTEIN DEFICIENCEIS BY GENE THERAPY
通过基因疗法纠正遗传性蛋白质缺陷
- 批准号:
6290532 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship Programs
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
-- - 项目类别: